EQS-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Joint Venture
Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for the.
EQSAdhoc Eckert & Ziegler Strahlen und Medizintechnik AG Key word Joint Venture Eckert & Ziegler Establishes GermanChinese Joint Venture with DC Pharma for the Production of Radioisotopes 14N
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): ContractEckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials 23.10.2023 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Berlin, Germany and Shanghai, China – 23 Octob.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company DecisionEckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG 20.10.2023 / 15:40 CET/CESTThe issuer is solely responsible for the cont.
EQSAdhoc Eckert & Ziegler Strahlen und Medizintechnik AG Key word Strategic Company Decision Eckert & Ziegler Focuses on Core Competence and Prepares SplitOff of Clinical Assets 20Oct2023 151